Study of a new drug for cancers that spread to the brain or spinal cord
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This study tests a new drug called MT027 for people whose solid tumors (like lung, breast, or colon cancer) have spread to the brain, the lining of the brain, or the spinal cord. It aims to see if the drug is safe and can help shrink or control these cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have a confirmed solid tumor (such as lung, breast, colon, melanoma, or kidney cancer) that has spread to the brain, the lining of the brain, or the spinal cord.
- You are expected to live at least 3 more months.
- You are able to care for yourself and perform normal activities (Karnofsky score of 70 or higher).
- You are not allergic to the study drug and do not have severe heart, lung, liver, or kidney problems, or certain other conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to choose treatment for people with brain tumors that have not responded to standard therapies. Your tumor sample is analyzed in the lab to find which drugs might work best for you, and then you receive a personalized treatment plan.
This trial tests a new drug, NBQ72S, for people with breast cancer that has spread to the lining of the brain or spinal cord (leptomeningeal metastasis). It aims to see if the drug is safe and helpful for these patients.
This trial tests a new drug called MT027 for people with advanced cancer that has spread to the lining around the lungs (pleura) and caused fluid buildup. The drug targets a marker on cancer cells called B7-H3. It may help control the fluid and the cancer.
This study looks at how well a new anti-tumor drug works when given along with radiation therapy for people whose advanced breast cancer has spread to the brain. It may help the radiation work better and control the cancer longer.
This trial tests a new drug, SCTB39G, for people with advanced solid tumors that haven't responded to other treatments. The goal is to see if it can shrink tumors and improve survival, and to find the best dose. Participation involves regular treatment and check-ups.
This trial tests a new drug called JSKN027 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if this drug is safe and if it can shrink tumors or slow their growth.
Hear when a new Brain (Nervous System) Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.